RVNC
Revance Therapeutics, Inc.
CFO, CBO, Secretary Lauren P Silvernail sold $640K of Revance Therapeutics, Inc.
Sold$640,000
$32.00Price
20,000Shares
−22%Stake
What RVNC did after the filing
Prices for RVNC after this filing aren't in yet.
Traded Wed, Mar 7. Filed Fri, Mar 9, 3:34 PM ET, during the session. Not investment advice.